Atlas Trials

Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients

Clinical trial NCT05927064 · COMPLETED

Trial details

NCT number
NCT05927064
Sponsor
Central Hospital, Nancy, France
Status
COMPLETED
Study type
OBSERVATIONAL
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Start date
2023-07-21
Primary completion
2024-01-12
Enrollment
1282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.